Study findings call for paradigm shift in standard of care
Refinements introduced to Cleveland Clinic-developed approach to a rare defect
But it is no substitute for clinical judgment
Cleveland Clinic-led study supports investigation of similar immunomodulatory therapies
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Intermediate-term results of REGROUP trial extend earlier findings
And two case vignettes where some of them come into play
Cleveland Clinic team publishes its experience ensuring safe delivery of essential care
How the technology helped maintain transplant volume during a pandemic year
Our outcome and volume highlights across a range of heart operations
Large Cleveland Clinic series underscores challenges of decision-making for this rare defect
Advertisement
Advertisement